Pharmena S.A. (WSE:PHR)
3.350
0.00 (0.00%)
Nov 3, 2025, 2:18 PM CET
Pharmena Market Cap
Pharmena has a market cap or net worth of 37.53 million as of November 3, 2025. Its market cap has decreased by -38.50% in one year.
Market Cap
37.53M
Enterprise Value
37.53M
Revenue
889.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.35
Market Cap Chart
Since August 25, 2008, Pharmena's market cap has decreased from 171.99M to 37.53M, a decrease of -78.18%. That is a compound annual growth rate of -8.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 37.53M | -12.01% |
| Dec 30, 2024 | 42.66M | -46.06% |
| Dec 29, 2023 | 79.08M | 26.79% |
| Dec 30, 2022 | 62.37M | -29.20% |
| Dec 30, 2021 | 88.10M | -10.89% |
| Dec 30, 2020 | 98.86M | 67.91% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.24B |
| NEUCA | 3.34B |
| Synektik Spólka Akcyjna | 2.24B |
| Voxel | 1.60B |
| Celon Pharma | 1.16B |
| Selvita | 677.32M |
| Centrum Medyczne ENEL-MED | 511.87M |
| Bioceltix | 477.67M |